Armstrong, Fleming & Moore, Inc
- SEC CIK
- 0001990099
- Latest filing
- Jul 28, 2026
PFE holding history
Pfizer Inc in every 13F filed by Armstrong, Fleming & Moore, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −9,868−100.0% | Sold out | Holders |
| Q1 2026 | 9,868 | $277.1K | 0.1% | +70+0.7% | Added | Holders |
| Q4 2025 | 9,798 | $244.0K | 0.1% | −57−0.6% | Reduced | Holders |
| Q3 2025 | 9,855 | $251.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 9,855 | $238.9K | 0.1% | +9,855 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −11,802−100.0% | Sold out | Holders |
| Q4 2024 | 11,802 | $313.1K | 0.2% | −707−5.7% | Reduced | Holders |
| Q3 2024 | 12,509 | $362.0K | 0.2% | +500+4.2% | Added | Holders |
| Q2 2024 | 12,009 | $336.0K | 0.2% | −126−1.0% | Reduced | Holders |
| Q1 2024 | 12,135 | $336.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 12,135 | $349.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 12,135 | $402.5K | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2023 | 12,135 | $445.1K | 0.4% | – | No prior filing | Holders |